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Introduction
10) and in serum or plasma (9, 11) , we have to take
Although several studies have been reported on the lipid ac ' ount of different ^ncentration ranges and decision and lipoprotein concentrations of newborns and children levels -rt is to be ex P ected that »Poprotein(a) levels in (l -6), relatively few studies have been reported on the wh°k b !°o d are approximately half those in seruni or establishment of reference ranges for lipoprotein(a) in plasma, and that they are related to the haematocrit. these groups (7) (8) (9) (10) (11) . Since lipoprotein(a) levels for Contradictory reports on the serum or plasma levels of newborns have been determined both in blood spots (8, lipoprotein(a) düring pregnancy and postpartum have been published (12, 13) ; the use of different methodology may account for the differences found (12) . At presence there is little or no treatment for diminishing lipoprotein(a) levels in blood (with the exception of the HELP apheresis) but there is a need for the early recognition of children at risk of developing atherosclerotic disease due to abnormally high levels of lipoprotein(a). Even for adults, the recommended upper limits of lipoprotein(a) (14) have been accepted without sufficient investigation or statistical analysis.
This study was implemented to study the concentrations of lipoprotein(a) in newborns, children, adolescents and adults, using a single method of detection (15) . Capillary and cord blood concentrations of lipoprotein(a) in newborns were compared, in order to establish age-linked reference ranges, and to establish files on newborns with elevated lipoprotein(a), so that they can be observed more frequently and be treated s soon s this becomes possible. As lipoprotein(a) is accepted s an independent risk factor N for atherosclerosis, its serum concentration can be used to assess the general risk for early cardiovascular disease (8) , together with the other more generally accepted lipid and lipoprotein analytes such s total cholesterol, triacylglycerols and LDL-cholesterol (16) .
One advantage of the present study is that all results were obtained using a single lot of reagents, including Standard material. This is of importance, because there are no accepted reference materials for lipoprotein(a), and different methods give rise to different results (15) , so that comparison of results is often difficult.
Materials and Methods

Subjects studied
Newborns (n = 123) in the gynaecological clinic were examined for lipoprotein(a) levels using cord blood samples, and where possible, capillary blood. As the determination of lipoprotein(a) required only ΙΟμΙ serum, no problems were encountered. At the same time, the lipoprotein(a) concentration of the mother was also measured in serum. If the father was present at the birth, he was asked whether he would allow blood to be taken for lipoprotein(a) determination.
In addition, lipoprotein(a) was determined in serum from 331 inpatient children from the paediatric wards, using samples taken for routine laboratory tests. None of the children had been admitted because of a known lipid disorder.
Lipoprotein(a) concentrations were also measured in the serum of 252 non-selected patients from all wards of the Hospital to cover the age r nge 17-88 years.
Methods of analysis
Lipoprotein(a) was determined using an immunoluminonietric assay s already described and published in this Journal (15) . As the samples must be diluted 1:10 before assay, using a sample size < of 10 μΐ, the method was suitable for samples from neonates arid children.
In certain selectcd cases with elevated lipoprotein(a), serum was subjected to lipid electrophoresis and analysed for triacylglycerols and cholesterol. Resialts frorn these cases are not presented here.
Statistics
As it is known that lipoprotein(a) is npt normally distributed, nonparametric tests were used. The mediari was used s the point of ceutral tendency, the dispersion being given in tefms of relevant percentiles. Correlations were made using the Spearman rank corr elation procedure.
Results
Newborns
Although 123 newborns were included in the study, it was not possible to obtain cord blood and capillary blood from each baby, so that only 37 newborns could be included in this group.
Figure l shows the lipoprotein(a) concentrations in cord blood plotted against those in capillary blood. As can be seen, the correlation was good, with several exceptions, where the cord blood concentration lay between the maternal and newbora value. The most extreme cases were: maternal serum 27.6 mg/1, cord blood 103 mg/1, newborn serum 267 mg/1 and maternal serum 150 mg/l, cord blood 68.5 mg/1, newborn serum 26.7 mg/1. Combinations such s: maternal serum 1400 mg/1, newborn serum 14.9 mg/l* i.e. mother high, baby low, were not uncommon. These values are given to show that the measured lipoprotein(a) concentration of cord blood is not always a reliable index of the serum concentrations. Whenever the concentrations in cord and capillary blood were discrepant, there was also a large difference between maternal and offspring lipoprotein(a) levels. The median value of the lipoprotein(a) concentrations in newborns lay well below those found in children older than 6 months, and in adülts. There was a slight, but insignificant correlation between lipoprotein(a) concentrations at birth and the gestational age, more prematurely born babies having lower values on average, äs seen in figure 2 . Figure 3a shows the distribution of lipoprotein(a) values in the cord blood of newborns. The median value for lipoprotein(a) in cord blood was 13.9 mg/1 (ränge < l -354 mg/1) and in capillary blood 10.2 mg/1 (ränge < 1-336 mg/1). The values were logarithmically distributed. In one case, where the mother had a lipoprotein(a) value of 1150 mg/1, the lipoprotein(a) values in the baby rose from 125 mg/1 at birth to 169, 264 and 344 mg/1 on days 2, 6 and 9 postpartum. During the study, two women gave birth to heterozygotic twins, in each case a boy and a girl. In the one case, the lipoprotein(a) levels were 3.2 and 3.4 mg/1. The other twins presented with metabolic problems and were admitted to hospital at 6 months. The lipoprotein(a) levels were found to be 684 and 712 mg/1. This demonstrates the non sex-linked codominant inheritance of lipoprotein(a) attributes (17, 18) .
Children and adolescents (age l month to 16 j years) )i Figure 2 shows the distribution of median lipoprotein(a) ! » concentrations in serum with age. It is clear that although lipoprotein(a) levels are genetically codominantly determined, the peak values in serum do not appear to be reached before the end of the sixth decade of life, the median values sinking thereafter. Figure 3b shows the individual values from 331 children sorted according to age. Both parents of one child (age 6 years, with lipoprotein(a) concentrations above 2.3 g/l) had elevated levels (mother 945 mg/1, father 1345 mg/1), thus further supporting the codominant (double-dose) inheritance.
It was surprising how many children in the first year of life presented with highly elevated lipoprotein(a) concentrations, levels of above l g/l being found. The scatter of results is reflected in tables l and 2, and figure 3b. This is applicable to all age groups.
Adülts
Although the results in figure 2 are from non-selected hospitalised patients, a comparison was made with the women who were only in hospital to give birth. The comparison between hospitalised patients of both sexes between 17 and 35 years and mothers of the same age can be seen in table 1. Figure 3c shows the individual results from 252 adülts.
Tabular and graphical data for all groups 
Discussion
The aim of the study was to try to establish reference •ranges for lipoprotein(a) for newbonis and children.
From the results obtained, it can be stated that lipoprotein(a) reference ränge values can be defined for newborns, infants up to 6 months and children from 6 months to 16 years. The data presented here would support the use of an age-dependent recommended upper limit for lipoprotein(a) concentrations in serum. From the data in table 2, suggested warning limits are above Week of pregnancy at birth The groups comprised 123 newboms, 331 children, 252 adults, 80 mothers and 51 age-matched others. The asterisks denote that the groups were too small for these values to have any statistical meaning. There was no significant difference between the sexes, except for the adults, where males had higher values than females (p < 0.05).
Tab. 25 mg/1 for newborns in cord blood or serum, above 150 rng/1 for children, above 200 mg/1 adolescents and above 300 mg/1 for adults when the 75th pereentile value is taken äs in the Framingham second generation study (19) . A sliding scale woüld be naore applicable in terms of the results in figure 2* äs the median values increase continuously from birth to the end of the sixth deeade of life. These values can only be taken äs a guide, äs the number of observations is too small for setting limits.
The results are interesting inasmuch äs they show that high lipoprotein(a) concentrations are observable within the first months of life. Of the children admitted to hospital within the first year of life, 20% (10/50) showed lipoprotein(a) values above 200 mg/1. Lipoprotein(a) levels appear to reach maximal levels at the end of the sixth deeade of life, although a two-fold rise in lipoprotein(a) values during the first 8 days after birth was seen in 9/20 newborns, whose blood was taken for other tests. The general claim that lipoprotein(a) levels increase over the first 8 days of life (9) due to the maturation of lipoprotein(a) gene expression within this time (8) is not supported by the present study. The claim that lipoprotein(a) concentrations at 8 months were similar to those seen in adults (8, 9) could not be confirmed in the present study. In the limited number of children studied over the first 9 days of life the only observation made was that in 9/10 children with a cord serum lipoprotein(a) value over 25 mg/1, this value rose over the observation period by a factor of 2-3, the lOth child having a value which remained constant around 27 g/l.
No such incresae was observed in 10 children with lipoprotein(a) values at birth under 20 mg/1. These findings indicate that newborns with a lipoprotein(a) concentration above 25 mg/I should be checked again at around 6 months of age.
For ethical reasons, it was not possible to include a group of non-hospitälised healthy children for comparison. The fact that the children were admitted to the hospital without known lipid disorders would support the theory that the results presented here reflect the Situation in the general population. This is borne out further by comparison of the values of the mothers with those from both men and women of the same age, who were hospitalised.
It has been reported that apolipoprotein B synthesis at birth is only 30% of that found in adults, and the synthesis of this apolipoprotein reaches adult levels after 7 days (9). The low concentrations of lipoprotein(a) reported here are not, however, due to a low synthesis of apolipoprotein(a). The assay used in the present study employed two antibodies directed against apolipoprotein(a), i.e. the sandwich partner was not directed against apolipoprotein B, although such an assay has been published from this laboratory (15) . Other authors (9) have shown that the synthesis of apolipoprotein(a) first reaches maturity after about 180 days. The present results show that the ränge of values seen at about 6 months is-similar to that in adults, although the median value is lower (flg. 3a).
An interesting observation was that the median lipoprotein(a) values in males decreased after the completion of the 6th decade of life. This is not due to decreased synthesis, but due to the death of those with high lipoprotein(a) from atherosclerotic and cardiovascular disease. All patients older than 70 and with grossly elevated lipoprotein(a) (over l g/l) were women. The spread of results, äs seen in table l, shows that the concentrations of lipoprotein(a), äs well äs being log-normally distributed, have a sinailar distribution (mean/median) throughout life.
The logarithmic distribution of results can be seen clearly from all figures, yet many research groups still give concentrations in terms of mean and Standard deviation, although this has been rightly criticised äs reducing the value of such publications (20) .
The most striking findings were that the lipoprotein(a) median concentrations follow the "stress-curve" of life, peaking exactly during the 15 years where the most myocardial infarction cases occur. One must postulate that although lipoprotein(a) disposition is genetieally determined, lipoprotein(a), like the other lipid "risk factors" is affected by the stress of daily life. This point must be taken into account wheii advising the parents of children and adolescents to adopt a life style where stress is kept to a minimum. A dietary education pro* gramme for children with elevated cholesterol levels has already been published and is based on both dietary, äs well äs "hands-on" therapy (21) .
Current concepts must be changed äs new facts concerning lipoprotein(a) come to light, especially if the hypothesis that the size of the lipoprotein(a) molecule influences its atherosclerotic effects proves to be correct.
Finally, it must be stated that the results here are from deflned groups of subjects of Caucasian origin, and in the light of other studies on lipid analytes (22-24) may not be transferable to other ethnic groups ör to mixed populations, although studies on black and white öew-borns (11) have shown no diiference in lipoprotein(a) concentrations at birth between the two races.
